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Abstract
To compare the quality of life (QOL) in patients with ileal neobladder and sigmoidal neoblad-
der, a retrospective survey was conducted using a formulated questionnaire. Between January
and March 1999, a QOL survey was conducted using self-administered questionnaires (EORTC
QLQ-C30, IP, supplemented with detailed questionnaires about continence, sexual function, and
patient’s satisfaction with the selected urinary diversion method) for 78 patients with orthotopic
urinary reservoir (OUR) who were followed-up for more than 3 months after cystectomy. Among
78 patients, 63 had OUR using an ileal segment (male/female&#xFF1D;59/4, median age: 70.8
years old, median follow-up: 1.7 years). Fifteen patients had OUR using a sigmoidal segment
(male/female&#xFF1D;13/2, median age: 71.9, median follow-up: 3.9). The QLQ-C30 func-
tional evaluation and the items in relation to sexual function showed no diff erences between the 2
groups. Concerning the voiding condition, bladder emptying, frequency, and urgency, scores in the
sigmoidal OUR group were signifi cantly higher. The QOL score concerning voiding conditions,
daytime, and nighttime continence and quantity of pad showed a better score in the ileal OUR
group. Concerning the satisfaction with methods of urinary diversion, patients in the sigmoidal
OUR group expreed le satisfaction than their preoperative expectations. Considering several post-
operative voiding conditions, ileal OUR seems superior to sigmoidal OUR.
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adical cystectomy with urinary tract recon-
struction currently remains the standard treat-
ment for invasive bladder cancer.  During the last 
decade orthotopic urinary reservoirs (OUR) have 
become a gold standard for urinary tract reconstruc-
tion after radical cystectomy for invasive bladder 
cancer to improve patient quality of life (QOL) [1ﾝ
16],  even for elderly patients [17].  Generally,  an 
OUR is a constructed spherical pouch using a detubu-
larized bowel segment,  to which the ureteral implan-
tation and the urethro-neobladder anastomosis is per-
formed.  Various bowel segments are used for OUR 
with the ileum and sigmoid colon being used most fre-
quently [1,  2,  18ﾝ20].  With experience,  complica-
tion rates and operative times have been reduced,  and 
studies have shown that the type of OUR performed 
has no impact on cancer control in carefully selected 
patients.  Therefore,  other factors should be consid-
ered when deciding which kind of OUR is suitable for 
each patient.  Apart from functionality and long-term 
R
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complications,  QOL is important when deciding which 
diversion is appropriate.  However,  diﬀ erences in 
QOL which depend on the type of OUR have rarely 
been reported [21].
Materials and Methods
　 Between January and March 1999,  a QOL survey 
was conducted using self-administered questionnaires 
for 78 patients with OUR who were followed-up for 
more than 3 months after radical cystectomy at the 
Okayama University Hospital and its aﬃ  liated hospi-
tals (the Okayama Urological Research Group 
(OURG)).  The surgical procedures were based on the 
original Hautmann method,  the Studer method,  or the 
Reddy method [1].  Patients were considered disease-
free when their last follow-up visit,  including a physi-
cal examination,  chest X-ray,  and CT of the abdomen 
and pelvis,  showed no evidence of local or distant 
recurrence.
　 A health-related QOL (HRQOL) assessment was 
performed using the European Organization for the 
Research and Treatment of Cancer Quality of Life 
Core Questionnaire (EORTC-QLQ-C30) [22] devel-
oped to measure basic components of HRQOL that are 
similar for most malignancies.  This comprises 5 func-
tional scales covering physical,  role,  emotional,  cog-
nitive and social aspects,  one scale of overall health 
status,  and overall HRQOL.  There are also 3 symp-
tom scales of fatigue,  nausea/vomiting,  and pain,  and 
6 single items that deal with dyspnea,  insomnia,  appe-
tite loss,  constipation,  diarrhea,  and ﬁ nancial diﬃ  cul-
ties caused by the disease or its treatment.  Questions 
on the physical scale were answered using a dichoto-
mous response scale (yes/no),  while overall HRQOL 
was scored from 1 to 7 (very poor to excellent).  The 
other items were answered through a Likert scale,  and 
responses were graded from 1 to 4 (1＝not at all,  4
＝very much).  All scores were linearly transformed 
to a 0ﾝ100 scale.  For functional and overall scales,  
higher scores represent a better outcome on HRQOL,  
whereas for symptom and single-item scales,  higher 
scores correspond to more problems and a reduced 
HRQOL.
　 In addition to the above questionnaire,  the 
International Prostate Symptom Score (IPSS) sup-
plemented with detailed questionnaires about conti-
nence,  sexual function,  and patient’s satisfaction with 
the selected urinary diversion method designed by the 
Department of Urology in collaboration with the 
Department of Psychiatry,  were used to evaluate 
these patients.
　 QOL questionnaires and a cover letter explaining 
the nature of the survey were mailed to all partici-
pants in the study.  If there was no reply,  a reminder 
letter was sent,  followed by a telephone call,  if neces-
sary.
　 The results of the questionnaires were converted 
into scores and statistically analyzed using the Mann-
Whitney U-test.
Results
　 Among 78 patients,  63 had OUR using an ileal 
segment.  Their median age was 70.8 years (range 
32.0 to 90.4); median follow-up was 1.7 years (range 
0.2 to 8.1); there were 59 males and 4 females.  
Fifteen patients had OUR using a sigmoidal segment.  
Their median age was 71.9 years (range 54.4 to 
80.4); median follow-up was 3.9 years (range 1.9 to 
6.0); there were 13 male and 2 female patients (Table 
1).
　 The EORTC QLQ-C30 functional evaluation 
showed no statistically signiﬁ cant diﬀ erences on any 
item between the two groups (Fig.  1).
　 Regarding the EORTC QLQ-C30 symptom scales,  
diarrhea was recognized as being worse in the ileal 
OUR group,  and the diﬀ erence was statistically sig-
niﬁ cant (p＝0.0319).  No signiﬁ cant diﬀ erence 
between the 2 groups was recognized in other symp-
toms (Fig.  2).
　 In relation to sexual function,  no diﬀ erence 
between the 2 groups was recognized on any item in 
our questionnaires (Fig.  3).
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Table 1　 Patients’ characteristics
Urinary diversion Ileal neobladder Sigmoidal neobladder
No.  of cases 63 15
　n＝78
Sex (M/F) 59 :4 13 :2
Median age 70.8 71.9
(range) (32.0ﾝ90.4) (54.4ﾝ80.4)
Median follow-up 1.7 years 3.9 years
(range) (0.2ﾝ8.1 years) (1.9ﾝ6.0 years)
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　 Concerning voiding condition by the IPSS,  bladder 
emptying,  frequency,  and urgency scores in the sig-
moidal OUR group were signiﬁ cantly higher than 
those in the ileal OUR group (p＝0.0277,  0.0045 and 
0.0470,  respectively),  while no diﬀ erences between 
the 2 groups were recognized in scores reﬂ ecting 
intermittency,  weak stream,  straining,  and nocturia.  
The QOL score concerning voiding conditions in the 
sigmoidal OUR group was also lower (p＝0.0189) 
(Fig.  4).
　 Daytime and nighttime continence and quantity of 
pad showed a statistically signiﬁ cant better score in 
the ileal OUR group (p＝0.0075,  ＜0.0001 and 
0.0006,  respectively) (Fig.  5).
　 Regarding satisfaction with urinary diversion,  
more patients in the sigmoidal OUR group felt disap-
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Fig. 2　 EORTC QLQ-C30 Symptom scales: A high scale score 
represents a high level of symptomatic problems (0ﾝ100).  Diarrhea 
was worse in the ileal OUR group (p＝0.0319).
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Fig. 1　 EORTC QLQ-C30 Functional scales: A high scale score 
represents a high/healthy level of functioning (0ﾝ100).  No 
statistically signiﬁ cant diﬀ erences on any items.
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Fig. 3　 Sexual Function: A high score represents a high level of problems (0ﾝ3).  No statistically signiﬁ cant diﬀ erences on any items.
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pointment than those in the ileal OUR groups (Fig.  
6).
Discussion
　 While there are some diﬀ erences in post surgical 
course between the ileal OUR and sigmoidal OUR,  the 
current published literature does not conclusively 
document that one type of OUR is superior to another 
in terms of HRQOL.  The assessment of HRQOL out-
come is an important part of determining the overall 
eﬀ ectiveness and beneﬁ t of a particular therapy.  
HRQOL is most important in disease processes where 
the treatments yield similar cancer-speciﬁ c and sur-
vival results.  To make an informed decision,  patients 
need to know the after-surgery QOL that each tech-
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nique oﬀ ers.  However,  the assessment of HRQOL 
outcome in bladder cancer and type of urinary diver-
sion is in its preliminary stages.  To our knowledge,  
only one study has compared QOL between ileal OUR 
and Sigmoidal OUR [21].
　 We used EORTC-QLQ-C30 as a previously vali-
dated instrument for measuring the general aspects of 
HRQOL that are speciﬁ c to cancer.  However,  this did 
not address the domains of speciﬁ c relevance to 
patients with bladder cancer.  While the functional 
evaluations showed no diﬀ erences between the 2 
groups,  as for the symptom scales,  diarrhea was rec-
ognized as being worse in the ileal than the sigmoidal 
OUR group.  This result may indicate the possibility 
of indigestion at the ileal region and patients who are 
candidates for ileal OUR should be informed that they 
may need to take anti-dyspeptic diarrhea medicine.
　 Unfortunately,  general instruments may not be 
very responsive to changes speciﬁ c to bladder cancer 
and urinary diversion.  EORTC-QLQ-C30 does not 
speciﬁ cally address issues such as erectile dysfunction 
or urinary incontinence.  Some preliminary work has 
been performed to develop and validate bladder can-
cer/urinary diversion-speciﬁ c instruments [23],  but 
as of now no well-studied instrument for measuring 
HRQOL in the setting of bladder cancer and urinary 
diversion is available.  The FACT-Bl has undergone 
some validation,  but even this instrument has not been 
well-researched and may not be very responsive [14].  
Therefore,  we used our original questionnaires and 
the IPSS for evaluating subjective/objective condi-
tions of urination and sexual function.  While no dif-
ference was recognized in sexual function between the 
2 groups,  bladder emptying,  frequency,  and urgency 
scores of IPSS in the sigmoidal OUR group were 
signiﬁ cantly higher than those in the ileal OUR group.  
Furthermore,  daytime and nighttime continence and 
quantity of pad showed obviously better scores in the 
ileal OUR group.  Results show that the QOL scores 
of IPSS in the sigmoidal OUR group were inferior,  
and patients in the group felt less satisfaction than 
their preoperative expectations.  The possible reason 
for the diﬀ erence are,  as Koraitim et al.  [24] have 
shown,  that the ileal OUR can provide a greater-
capacity,  lower-pressure reservoir with greater com-
pliance and less-frequent involuntary contractions than 
the sigmoidal OUR .
　 Our results are diﬀ erent from those of Miyake et 
al.  [21],  especially concerning urinary symptoms and 
patient’s satisfaction.  There are several possible rea-
sons: ﬁ rst,  the age distribution in the current study 
was older than that in the prior report (median 70.8 in 
ileal OUR and 71.9 sigmoidal versus mean 62.3 and 
55.8 years old) although no inﬂ uence of age distribu-
tion in our series could be found; second,  the duration 
of follow-up in the current study was diﬀ erent from 
that reported previously (median 20.4 in ileal OUR 
and 46.8 sigmoidal versus mean 40.2 and 43.1 
months),  and third,  the current study consisted of 72 
males and 6 females.  The greatest limitation of both 
studies was the lack of baseline and longitudinal 
assessment of HRQOL.  Prospective studies with lon-
233Ileal versus Sigmoidal NeobladderAugust 2007
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Fig. 6　 Satisfaction with methods of urinary diversion: A high score represents a high level of problems.  Patients in the sigmoidal OUR 
group expressed less satisfaction than their preoperative expectations.
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gitudinal data collection to measure HRQOL could 
answer many of the important questions regarding 
HRQOL and the type of OUR.
　 Since the current study was a retrospective analy-
sis involving a relatively small number of patients,  the 
results are not suﬃ  ciently conclusive regarding the 
superiority of HRQOL in the ileal OUR for bladder 
cancer.  However,  some potentially useful information 
may be gained reﬂ ecting preoperative informed con-
sent,  as well as the selection of the type of urinary 
diversion and postoperative care.
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